Literature DB >> 15180873

Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia.

Lan-Phuong Dao-Ung, Stephen J Fuller, Ronald Sluyter, Kristen K SkarRatt, Ulf Thunberg, Gerard Tobin, Karen Byth, Maria Ban, Richard Rosenquist, Graeme J Stewart, James S Wiley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15180873     DOI： 10.1111/j.1365-2141.2004.04976.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis.

Authors:  Wen-Jun Zhang; Zheng-Ming Zhu
Journal:  Purinergic Signal       Date:  2020-10-07       Impact factor: 3.765

Review 3.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

4.  Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.

Authors:  Chengqun Sun; Jessica Chu; Sarita Singh; Russell D Salter
Journal:  Purinergic Signal       Date:  2009-10-17       Impact factor: 3.765

5.  The P2X(7) receptor and intracellular pathogens: a continuing struggle.

Authors:  Robson Coutinho-Silva; Gladys Corrêa; Ali Abdul Sater; David M Ojcius
Journal:  Purinergic Signal       Date:  2009-02-12       Impact factor: 3.765

6.  Predicted the P2RX7 rs3751143 polymorphism is associated with cancer risk: a meta-analysis and systematic review.

Authors:  Bi-Jun Wang; Jun-Yi Chen; Yu Guan; Da-Chao Liu; Zi-Chuan Cao; Jin Kong; Zheng-Sheng Wu; Wen-Yong Wu
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

7.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

Review 8.  Non-synonymous single nucleotide polymorphisms in the P2X receptor genes: association with diseases, impact on receptor functions and potential use as diagnosis biomarkers.

Authors:  Emily A Caseley; Stephen P Muench; Sebastien Roger; Hong-Ju Mao; Stephen A Baldwin; Lin-Hua Jiang
Journal:  Int J Mol Sci       Date:  2014-07-30       Impact factor: 5.923

9.  Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.

Authors:  Anna Solini; Vittorio Simeon; Lisa Derosa; Paola Orlandi; Chiara Rossi; Andrea Fontana; Luca Galli; Teresa Di Desidero; Anna Fioravanti; Sara Lucchesi; Luigi Coltelli; Laura Ginocchi; Giacomo Allegrini; Romano Danesi; Alfredo Falcone; Guido Bocci
Journal:  Oncotarget       Date:  2015-10-06

10.  Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.

Authors:  Aparna Raval; Stephan M Tanner; John C Byrd; Elizabeth B Angerman; James D Perko; Shih-Shih Chen; Björn Hackanson; Michael R Grever; David M Lucas; Jennifer J Matkovic; Thomas S Lin; Thomas J Kipps; Fiona Murray; Dennis Weisenburger; Warren Sanger; Jane Lynch; Patrice Watson; Mary Jansen; Yuko Yoshinaga; Richard Rosenquist; Pieter J de Jong; Penny Coggill; Stephan Beck; Henry Lynch; Albert de la Chapelle; Christoph Plass
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.